|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Revenue | |||
| Cost of sales | |||
| Gross profit | |||
| Selling expenses | |||
| General administration expenses | |||
| Research and development | |||
| Other income | |||
| Other expenses | |||
| Listing expenses | |||
| Reversal on impairment on financial assets | |||
| Operating profit (loss) | |||
| Finance income | |||
| Finance expenses | |||
| Financial result | |||
| Share of profit (loss) in joint ventures | |||
| Share of loss from equity method investees | |||
| Income (loss) before income tax | |||
| Income tax benefit (expense) | |||
| Net income (loss) for the period | |||
| Exchange differences on translation of foreign business units | |||
| Remeasurement of defined pension benefit obligation | |||
| Income tax on remeasurement of defined pension benefit obligation | |||
| Total items that will not be subsequently reclassified to profit or loss | |||
| Other comprehensive income (loss) | |||
| Total consolidated comprehensive income (loss) for the reporting period | |||
| Net income (loss) attributable to | |||
| Owners of SCHMID | |||
| Non-controlling interests | |||
| Total consolidated comprehensive income (loss) attributable to | |||
| Owners of SCHMID | |||
| Non-controlling interests | |||
| Earnings per share for profit / (loss) from continuing operations attributable to the ordinary equity holders of the company: | |||
| Basic earnings per share (in dollars) | |||
| Diluted earnings per share (in dollars) |
Loading...